A federal judge in Pennsylvania has given final approval to a $4 million settlement—of which $1.3 million is devoted to attorney fees—that resolves securities litigation against pharmaceutical company Zynerba.

The payout settles litigation involving claims that Zynerba violated the Securities and Exchange Act and was approved by U.S. District Judge Nitza Quiñones Alejandro of the Eastern District of Pennsylvania.